IPCA Labs share price has plunged 6% and is presently trading at Rs 1,493.0.
Meanwhile, the BSE HEALTHCARE index is at 42,783.0 (down 0.7%).
Among the top losers in the BSE HEALTHCARE index today are ERIS LIFESCIENCES (down 2.9%) and MAX HEALTHCARE INSTITUTE (down 2.5%).
ASTRAZENECA PHARMA (up 3.6%) and GSK Pharma (up 1.9%) are among the top gainers today.
Over the last one year, IPCA Labs has moved up from Rs 997.8 to Rs 1,493.0, registering a gain of Rs 495.3 (up 49.6%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 42,783.0, registering a gain of 55.6% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 214.3%), Glenmark Pharma (up 120.3%) and SUVEN PHARMACEUTICALS (up 117.9%).
Don't Miss: Key Information for Long-term Investors
The BSE Sensex is at 79,921.1 (down 0.4%).
The top losers among the BSE Sensex today are JSW Steel (down 1.4%) and Power Grid Corp. (down 1.3%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,512.0 (up 0.2%). Bajaj Finance and Bajaj Finserv are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 79,921.1, registering a gain of 15,349.3 points (up 23.8%).
IPCA Labs net profit grew 19.7% YoY to Rs 1,990 million for the quarter ended June 2024, compared to a profit of Rs 1,662 million a year ago. Net sales rose 32.0% to Rs 20,926 million during the period as against Rs 15,852 million in April-June 2023.
For the year ended March 2024, IPCA Labs reported 7.6% increase in net profit to Rs 5,292 million compared to net profit of Rs 4,919 million during FY23. Revenue of the company grew 23.6% to Rs 76,198 million during FY24.
The current Price to earnings ratio of IPCA Labs, based on rolling 12 month earnings, stands at 67.4.
Equitymaster requests your view! Post a comment on "IPCA Labs Plunges 6%; BSE HEALTHCARE Index Down 0.7%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!